Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy

PM R. 2012 May;4(5):383-4. doi: 10.1016/j.pmrj.2011.11.008.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Carbidopa / adverse effects*
  • Carbidopa / therapeutic use
  • Cerebral Palsy / complications*
  • Cerebral Palsy / drug therapy
  • Child
  • Dopamine Agents / adverse effects
  • Dopamine Agents / therapeutic use
  • Drug Therapy, Combination
  • Dystonia / complications
  • Dystonia / drug therapy*
  • Follow-Up Studies
  • Humans
  • Levodopa / adverse effects*
  • Levodopa / therapeutic use
  • Male
  • Neuroleptic Malignant Syndrome / etiology*

Substances

  • Dopamine Agents
  • Levodopa
  • Carbidopa